
FDA Accepted New Use for Kidney Disease Drug
The application seeks approval for KERENDIA to treat chronic kidney disease in adults without diabetes.
Live Poll
Do you trust pharmaceutical companies to prioritize treatment research for the most common chronic conditions?

